Other drugs

DRUG3 trials

Sponsors

The Affiliated Hospital of Hangzhou Normal University, Cardenal Herrera University, Lixiaoling

Conditions

Chronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2Chronic Kidney Disease stage3Chronic Kidney Disease stage4CirrhosisDiabetes Mellitus, Type 2Metabolic Dysfunction-associated Fatty Liver DiseaseObesity

Unknown Phase

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Not yet recruitingNCT06135584

The Affiliated Hospital of Hangzhou Normal UniversityMetabolic Dysfunction-associated Fatty Liver Disease, Cirrhosis

Start: 2023-11-18End: 2026-12-31Target: 1000Updated: 2023-11-18

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

RecruitingNCT07309094

Cardenal Herrera UniversityChronic Kidney Disease stage3, Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 1 +3

Start: 2023-09-15End: 2028-12-31Target: 250Updated: 2025-12-30

A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors

Active, not recruitingNCT07387874

LixiaolingRecurrent or Metastatic Solid Tumors

Start: 2025-07-10End: 2028-07-01Target: 30Updated: 2026-02-04